Related Experiment Video
Updated: Jun 7, 2025

Genome-wide Purification of Extrachromosomal Circular DNA from Eukaryotic Cells
Published on: April 4, 2016
Extrachromosomal circular DNA and their roles in cancer progression
Siqi Zheng1, Yunong Li1, Lin Wang1
1Department of Pharmacology, School of Pharmacy, China Liaoning Key Laboratory of Molecular Targeted Anti-Tumor Drug Development and Evaluation, Liaoning Cancer Immune Peptide Drug Engineering Technology Research Center, Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors, Ministry of Education, China Medical University, Shenyang, Liaoning 110122, China.
Abstract:
Extrachromosomal circular DNA (eccDNA), a chromosome-independent circular DNA, has garnered significant attention due to its widespread distribution and intricate biogenesis in carcinoma. Existing research findings propose that multiple eccDNAs contribute to drug resistance in cancer treatments through complex and interrelated regulatory mechanisms. The unique structure and genetic properties of eccDNA increase tumor heterogeneity. This increased diversity is a result of eccDNA's ability to stimulate oncogene remodeling and participate in anomalous splicing processes through chimeric cyclization and the reintegration of loop DNA back into the linear genome. Such actions promote oncogene amplification and silencing. eccDNA orchestrates protein interactions and modulates protein degradation by acting as a regulatory messenger. Moreover, it plays a pivotal role in modeling the tumor microenvironment and intensifying the stemness characteristics of tumor cells. This review presented detailed information about the biogenesis, distinguishing features, and functions of eccDNA, emphasized the role and mechanisms of eccDNA during cancer treatment, and further proposed the great potential of eccDNA in inspiring novel strategies for precision cancer therapy and facilitating the discovery of prognostic biomarkers for cancer.
Insights
Extrachromosomal circular DNAs (eccDNAs) drive cancer drug resistance and tumor heterogeneity. Understanding eccDNA biogenesis and function offers new avenues for precision cancer therapy and biomarker discovery.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Extrachromosomal circular DNAs (eccDNAs) are increasingly recognized for their roles in cancer.
- Their presence is linked to complex regulatory mechanisms influencing cancer progression and treatment resistance.
Purpose of the Study:
- To review the biogenesis, features, and functions of eccDNA in cancer.
- To emphasize eccDNA's role in cancer treatment and its potential for therapeutic strategies and biomarker development.
Main Methods:
- Literature review of existing research on eccDNA in carcinoma.
- Analysis of eccDNA's impact on oncogene remodeling, splicing, protein interactions, and the tumor microenvironment.
Main Results:
- eccDNA contributes to drug resistance and increases tumor heterogeneity through oncogene amplification and silencing.
- eccDNA influences protein interactions, degradation, tumor microenvironment modulation, and cancer stemness.
Conclusions:
- eccDNA biogenesis and functions are critical in cancer development and treatment.
- Targeting eccDNA holds promise for novel precision cancer therapies and identifying prognostic biomarkers.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Epigenetic Regulation
X-chromosome...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation
Induced Pluripotent Stem Cells
Somatic...
Inheritance of Chromatin Structures

